Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
Apr 20, 2024, 19:03 |
Blog
How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases - FDA Oncology
FDA Oncology shared on X/Twitter: "How Much is Enough? Trial Designs for Treatment Regimens with…
Apr 20, 2024, 17:31 |
Blog
The U.S. FDA recently approved two CAR T-cell therapies for earlier treatment of adults with multiple myeloma - The Leukemia and Lymphoma Society
The Leukemia and Lymphoma Society shared a post on LinkedIn: "PROGRESS! The U.S. FDA recently approved…
Apr 19, 2024, 15:52 |
Drugs
FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer based on ALINA trial
FDA, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following…
Apr 14, 2024, 11:39 |
Drugs
Nieves Martinez Lago: FDA approvals Tumor-Agnostic drugs
Nieves Martinez Lago, Medical Oncologist at University Hospital Complex of Ferrol, shared on X/Twitter: "FDA…
Apr 13, 2024, 13:13 |
Positive
Vivek Subbiah: An absolute honor to meet the legendary Rick Pazdur at the FDA Oncology!
Vivek Subbiah posted on X/Twitter: "An absolute honor to meet the legendary Rick Pazdur at…
Apr 13, 2024, 08:14 |
Blog
David Fajgenbaum: Did you know behind every FDA approved drug lies numerous potential disease applications considered by drug companies?
David Fajgenbaum, Associate Professor of Medicine at University of Pennsylvania School of Medicine, shared on X:…
Apr 13, 2024, 03:43 |
Blog
FDA ODAC voted 12-0. Historic victory in multiple myeloma
On April 12, 2024, FDA ODAC voted 12-0 in favor of using minimal residual disease…
Apr 11, 2024, 17:24 |
Insight
Thor Halfdanarson: SSTR avid thyroid nodules are not rare and often seen on SSTR PET scan
Thor Halfdanarson, Vice President for the North American Neuroendocrine Tumor Society, made the following post…
Apr 8, 2024, 16:01 |
Drugs
Rahul Gosain: Trastuzumab Deruxtecan now is FDA approved, Based on DESTINY-PanTumor02, DESTINY-Lung01, and DESTINY-CRC02
Rahul Gosain, Co-Founder of Oncology Brothers podcast and Director of Regional Infusion Services and Medical…
Apr 8, 2024, 03:54 |
Drugs
Paolo Tarantino: Trastuzumab deruxtecan is now FDA approved for ANY treatment-refractory HER2+ solid tumor
Paolo Tarantino, Advanced Research Fellow in the Breast Oncology Program at Dana-Farber Cancer Institute, shared…
15
16
17
18
19
All:
937
Posts:
161 - 170
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube